Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Remifentanil-induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans

NCT00785863 is registered in ClinicalTrials.gov with Ullevaal University Hospital as lead sponsor.

NCT NCT00785863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00785863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Remifentanil-induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans
Lead sponsor
Ullevaal University Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
April 30, 2009
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperalgesia, secondary